Dongchao Xu

1PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 15, 2022
Linderalactone Suppresses Pancreatic Cancer Development In Vitro and In Vivo via Negatively Regulating PI3K/AKT Signaling Pathway.

Dongchao Xu, Mengyao Tian, Wangyang Chen

Pageof 1

Frequent Collaborators

1 joint publications

Xiaofeng Zhang

1 joint publications

Hongzhang Shen